Convexity Meningioma Dural Repair: Graft Selection After Resection

In convexity meningioma surgery, the surgeon often removes the tumor's dural attachment together with the tumor, leaving a dural defect whose approximate size is visible on preoperative imaging. Because the defect is planned, the team can choose the graft type and size before the case, and the distributor can make sure the right product is on the shelf.

Meningiomas are among the most common tumors operated on in neurosurgery, and convexity meningiomas are a large share of them. For a dural graft supplier, tumor practices are important accounts: the cases are elective, the dural repair is part of the operative plan and the surgeons are often very particular about closure. This article focuses on convexity cases and explains how surgeons think about the graft and how a distributor can support them. For broader clinical background, see our article on meningioma resection and dural repair.

Why do meningioma resections so often need a graft?

Meningiomas arise from the meninges and are attached to the dura. Many surgeons aim to remove the tumor together with its dural attachment, and the extent of removal is classically described by the Simpson grading system, first published in 1957 and still widely referenced. Removing the attachment leaves a hole in the dura that usually cannot be closed by bringing the edges together.

At the convexity, where the dura is accessible and the anatomy relatively straightforward, surgeons can often excise a margin of dura around the attachment. The resulting defect can be large, and its size depends on the tumor's footprint and the margin taken. A graft is then needed to restore dural continuity.

Convexity cases differ from meningiomas at the skull base or along the venous sinuses. At the skull base, access to the dura can be limited and reconstruction is often layered. Near the sinuses, surgeons may leave part of the attachment rather than risk the sinus, which changes the defect. The convexity is where the planned excision of dura, and therefore the planned graft, is most common.

What makes convexity cases different for the graft supplier?

Three features distinguish convexity meningioma cases from many other dural repairs:

• They are planned. The surgeon knows before the operation that a graft will probably be needed.
• The defect size can be anticipated from imaging, at least approximately.
• The repair is usually accessible, so suturing is technically feasible if the surgeon prefers it.

For a distributor, that means the conversation can happen before the case, not in the middle of it. A tumor practice that schedules its cases in advance gives the distributor a chance to confirm that the right size is available on the day.

How do surgeons choose between sutured and onlay repair?

In convexity cases, both techniques are used. Some surgeons routinely suture a graft into the defect for secure fixation. Others use onlay grafts where they judge it appropriate, sometimes with a sealant. The choice depends on the surgeon's training, the size and position of the defect and the condition of the surrounding dura.

Many tumor surgeons also think about the layers above the dura. After a convexity resection, the bone flap is replaced and the scalp closed in layers, and some surgeons add a sealant over the dural repair. The graft is one part of a closure designed as a whole, which is why surgeons are often specific about which graft they want and how it should behave.

DESU's two membranes map to these choices. DURASHEET is a suturable dural graft matrix of pure Type I bovine collagen, usable on both surfaces. DECOLL is a collagen dura membrane of the same material, intended for onlay use. Both come in four sizes and are supplied ready to use and gamma sterilized.

How is the right size chosen?

For convexity defects, size selection follows the planned resection. The table below shows how surgeons typically think about it. It is a description of considerations, not a sizing rule.

Exact dimensions of each DESU size are in the catalog and IFU. A sensible approach for tumor practices is to keep the mid and larger sizes available, since convexity defects can be substantial.

What about bone involvement and the later layers?

Some convexity meningiomas involve the overlying bone, which may be thickened or invaded. When the bone flap is affected, the surgeon may remove and replace part of it, adding a cranioplasty step to the operation. The dural graft then sits beneath a reconstructed bone layer.

This does not usually change the choice of dural graft, but it changes the shape of the case and sometimes the products involved. The case may last longer, involve additional implants for bone reconstruction and require coordination between several suppliers. A distributor who understands the full sequence, from dural repair to bone reconstruction to closure, can have more useful conversations with the surgical team.

What do tumor surgeons ask about the graft?

Tumor surgeons tend to ask specific questions:

• "Which size covers a defect of this footprint, with my usual margin?"
• "How well does it conform over the brain surface after resection?"
• "Can I suture it with my usual suture?" (relevant for DURASHEET)
• "Can it be used as an onlay without fixation?" (relevant for DECOLL, per the IFU)
• "What biological evaluation has the material undergone?"
• "Who do I call if I have a question about a case?"

Answer from the IFU and documentation. If a question goes beyond them, refer it to DESU's specialists.

Some surgeons also ask about follow-up imaging, since meningioma patients are often monitored with MRI for years after surgery. Questions about how a graft appears on imaging are clinical and product-specific; refer them to DESU rather than offering general answers. A rep who takes these questions seriously, and comes back with the manufacturer's answer, earns a place in the surgeon's routine.

How can a distributor support a tumor practice?

The practical support that matters most to tumor practices includes:

Pre-case planning

Ask the surgeon or the OR coordinator to share, in general terms, which upcoming cases may need a graft and roughly what size. This allows stock to be checked in advance without any patient details being shared.

Size availability

Make sure the larger sizes are available, either on the shelf or on short notice. A tumor case should never be delayed because the right graft size is missing.

Documentation and continuity

Keep the IFU and documentation current, and make sure there is a contact who can answer technical questions quickly. Tumor surgeons value consistency, and a reliable distributor relationship becomes part of their routine.

Talk to a DESU product specialist

If you support neurosurgical tumor practices or are a hospital team reviewing dural grafts for meningioma surgery, DESU's product specialists can provide documentation and size details for DURASHEET and DECOLL and discuss what your market requires. Contact sales@desu.tr, use the contact page, or request a quote.